 |
|
|
| |
Darunavir (DRV)/r-based Postexposure Prophylaxis (PEP) versus standard of care (SOC) - quality of life in patients receiving PEP in a randomized study (PEPDar)
|
| |
| |
Reported by Jules Levin
20th International AIDS Conference, July 20-25, 2014, Melbourne
H. Jessen1, T. Kummerle2, A.B. Jessen1, A. Stoehr3, K. Arasteh4, J. Bogner5, C.D. Spinner6, C. Stephan7, O. Degen8, G. Fatkenheuer2, B. Ranneberg9, PEPDar-Study Group
1Praxis Jessen2 + Kollegen, Berlin, Germany, 2Uniklinik Koln, Klinik I fur Innere Medizin, Koln, Germany, 3IFI Institut fur Infektiologie, Hamburg, Germany, 4Auguste-Viktoria-Krankenhaus, Berlin, Germany, 5Ludwigs-Maximilians-Universitat, Medizinische Poliklinik, Munchen, Germany, 6Klinikum rechts der Isar, Interdisziplinares HIV-Zentrum, Munchen, Germany, 7Universitat Frankfurt, Zentrum der Inneren Medizin HIV-Center, Frankfurt, Germany, 8Universitatsklinikum Eppendorf, Hamburg, Germany, 9Janssen-Cilag, Neuss, Germany
|
| |
|
|
|
|
|
